Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
181,259,081
-
Total 13F shares
-
23,113,173
-
Share change
-
+5,478,525
-
Total reported value
-
$96,604,731
-
Put/Call ratio
-
2.8%
-
Price per share
-
$4.18
-
Number of holders
-
66
-
Value change
-
+$23,118,069
-
Number of buys
-
25
-
Number of sells
-
30
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q1 2024
As of 31 Mar 2024,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,113,173 shares.
The largest 10 holders included
VR Adviser, LLC, FMR LLC, Casdin Capital, LLC, Boxer Capital, LLC, BlackRock Inc., DAFNA Capital Management LLC, Avidity Partners Management LP, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, and BAKER BROS. ADVISORS LP.
This page lists
66
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.